UNICK FIX-A-FORM AND PRINTERS | SOTAC PHARMACEUTICALS LTD. | UNICK FIX-A-FORM AND PRINTERS/ SOTAC PHARMACEUTICALS LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.1 | - | - | View Chart |
P/BV | x | 1.1 | 13.7 | 8.1% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
UNICK FIX-A-FORM AND PRINTERS SOTAC PHARMACEUTICALS LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
SOTAC PHARMACEUTICALS LTD. Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ SOTAC PHARMACEUTICALS LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | NA | - | |
Low | Rs | 32 | NA | - | |
Sales per share (Unadj.) | Rs | 120.5 | 96.3 | 125.2% | |
Earnings per share (Unadj.) | Rs | 4.1 | 2.8 | 143.7% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 5.7 | 197.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 53.9 | 12.4 | 434.4% | |
Shares outstanding (eoy) | m | 5.49 | 8.05 | 68.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 0 | - | |
Avg P/E ratio | x | 11.1 | 0 | - | |
P/CF ratio (eoy) | x | 4.0 | 0 | - | |
Price / Book Value ratio | x | 0.8 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 248 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 26 | 348.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 775 | 85.4% | |
Other income | Rs m | 5 | 4 | 146.0% | |
Total revenues | Rs m | 667 | 778 | 85.7% | |
Gross profit | Rs m | 88 | 79 | 111.1% | |
Depreciation | Rs m | 39 | 23 | 171.9% | |
Interest | Rs m | 24 | 20 | 116.7% | |
Profit before tax | Rs m | 30 | 39 | 76.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 16 | 45.5% | |
Profit after tax | Rs m | 22 | 23 | 98.0% | |
Gross profit margin | % | 13.3 | 10.2 | 130.1% | |
Effective tax rate | % | 25.0 | 41.8 | 59.8% | |
Net profit margin | % | 3.4 | 3.0 | 114.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 471 | 63.8% | |
Current liabilities | Rs m | 287 | 458 | 62.6% | |
Net working cap to sales | % | 2.1 | 1.7 | 124.0% | |
Current ratio | x | 1.0 | 1.0 | 101.9% | |
Inventory Days | Days | 4 | 3 | 151.7% | |
Debtors Days | Days | 72,349,839 | 704 | 10,280,175.7% | |
Net fixed assets | Rs m | 402 | 265 | 151.6% | |
Share capital | Rs m | 55 | 81 | 68.1% | |
"Free" reserves | Rs m | 241 | 19 | 1,243.3% | |
Net worth | Rs m | 296 | 100 | 296.3% | |
Long term debt | Rs m | 89 | 78 | 114.2% | |
Total assets | Rs m | 705 | 736 | 95.8% | |
Interest coverage | x | 2.3 | 2.9 | 77.1% | |
Debt to equity ratio | x | 0.3 | 0.8 | 38.5% | |
Sales to assets ratio | x | 0.9 | 1.1 | 89.1% | |
Return on assets | % | 6.6 | 5.9 | 111.5% | |
Return on equity | % | 7.6 | 22.9 | 33.1% | |
Return on capital | % | 14.0 | 33.6 | 41.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | 0.0% | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 81 | 53.6% | |
From Investments | Rs m | -27 | -117 | 23.1% | |
From Financial Activity | Rs m | -16 | 131 | -12.4% | |
Net Cashflow | Rs m | 0 | 96 | 0.4% |
Indian Promoters | % | 71.6 | 72.9 | 98.2% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 9.0 | 5.0% | |
FIIs | % | 0.0 | 9.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 27.2 | 104.7% | |
Shareholders | 1,622 | 245 | 662.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | SOTAC PHARMACEUTICALS LTD. | S&P BSE TECK |
---|---|---|---|
1-Day | -3.15% | 0.00% | -0.02% |
1-Month | 17.42% | -6.02% | -1.38% |
1-Year | 55.44% | 1.68% | 26.22% |
3-Year CAGR | 28.92% | 0.56% | 10.25% |
5-Year CAGR | 21.03% | 0.33% | 14.86% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the SOTAC PHARMACEUTICALS LTD. share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of SOTAC PHARMACEUTICALS LTD. the stake stands at 72.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of SOTAC PHARMACEUTICALS LTD..
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
SOTAC PHARMACEUTICALS LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of SOTAC PHARMACEUTICALS LTD..
For a sector overview, read our media sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.